FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins
Bempedoic acid (Nexletol; Esperion) and bempedoic acid and ezetimibe (Nexlizet; Esperion) are the only LDL-C lowering non-statin drugs indicated for primary prevention patients.